Korea Investment CORP Cuts Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Korea Investment CORP lowered its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 25,580 shares of the company’s stock after selling 600 shares during the period. Korea Investment CORP’s holdings in Henry Schein were worth $1,770,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Charles Schwab Investment Management Inc. lifted its stake in shares of Henry Schein by 1.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company’s stock worth $82,464,000 after purchasing an additional 16,616 shares during the last quarter. ING Groep NV raised its holdings in Henry Schein by 34.1% in the fourth quarter. ING Groep NV now owns 1,163,087 shares of the company’s stock worth $80,486,000 after purchasing an additional 295,785 shares in the last quarter. Stifel Financial Corp lifted its position in shares of Henry Schein by 1.2% during the third quarter. Stifel Financial Corp now owns 1,122,455 shares of the company’s stock valued at $81,827,000 after buying an additional 13,180 shares during the last quarter. Holocene Advisors LP bought a new stake in shares of Henry Schein in the 3rd quarter valued at about $58,319,000. Finally, Amundi raised its stake in shares of Henry Schein by 12.0% during the 4th quarter. Amundi now owns 736,637 shares of the company’s stock worth $52,345,000 after acquiring an additional 79,056 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Insider Activity at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares in the company, valued at $1,762,147.20. The trade was a 9.50 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. UBS Group lowered their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Barrington Research reissued an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. Wells Fargo & Company assumed coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price on the stock. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Mizuho assumed coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective on the stock. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Henry Schein has an average rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Price Performance

Shares of HSIC opened at $69.07 on Wednesday. The business’s 50-day moving average is $74.42 and its two-hundred day moving average is $72.67. The company has a market capitalization of $8.58 billion, a P/E ratio of 28.42, a P/E/G ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.25 billion. During the same quarter in the prior year, the business posted $0.66 earnings per share. The firm’s revenue was up 5.8% compared to the same quarter last year. Research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.